Stephen Cunningham

Director/Board Member at Engrail Therapeutics, Inc.

Health Technology

Profile

Stephen Cunningham is currently the Director & Chief Development Officer at Engrail Therapeutics, Inc. He previously worked as a Director at Chase Pharmaceuticals Corp.

Stephen Cunningham active positions

Companies	Position	Start
Engrail Therapeutics, Inc. Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA.	Director/Board Member	-

All active positions of Stephen Cunningham

Former positions of Stephen Cunningham

Companies	Position	End
Chase Pharmaceuticals Corp. Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC.	Director/Board Member	-

See the detail of Stephen Cunningham's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stephen Cunningham's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Chase Pharmaceuticals Corp. Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC.	Health Technology
Engrail Therapeutics, Inc. Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA.	Health Technology